This resource provides information related to the SAPHNELO J-Code.
This letter contains a copy of the statement from the FDA approving SAPHNELO for use as recommended in the product labeling.
Download and complete the WAINUA Enrollment Form to request support for your patients.
This letter contains a copy of the statement from the FDA approving WAINUA for use as recommended in the product labeling.
This guide contains general information on support services, coding, reimbursement, and distribution for WAINUA.
This resource provides specific codes related to diagnosing and billing for WAINUA.
This sheet provides the contact information of authorized specialty pharmacy providers and specialty distributors through which WAINUA can be acquired.
This two-page resource describes how patients can get support for out-of-pocket costs for WAINUA if approved by insurance.
This resource explains affordability options for eligible patients who are prescribed WAINUA.
Checklists designed to be used as references during the prior authorization and denial/appeal processes for WAINUA.
This resource should be used as a guide to prepare for peer-to-peer reviews between a healthcare provider and payer after a denial of coverage for WAINUA.
This template can be used by a healthcare provider to appeal a denial of access to an AstraZeneca medicine.
This template can be used by a healthcare provider to appeal a denial of access to WAINUA.
This template can be used by a healthcare provider to appeal a denial of access to WAINUA.
This template can be used by a healthcare provider to respond to a patient’s insurance company requesting a letter of medical necessity for prescribing an AstraZeneca specialty medicine.
This guide provides resources and information to ensure you have all the tools you need to help navigate the denial of an AstraZeneca medicine.
The AstraZeneca Access 360™ program provides personal support and resources to help streamline access and reimbursement for select AstraZeneca medicines, including WAINUA. These resources include the Benefits Investigations Report, the Denial Management Guide, and the Peer-to-Peer resource.
